Two consultants from London’s Moorfields Eye Hospital restored vision for 24 young men in Bangladesh, following severe eye trauma sustained during pro-democracy protests. Medscape News UK
Category: News
Slow Adalimumab Tapering May Cut Risk for Uveitis Relapse
A retrospective cohort analysis shows that pediatric patients with noninfectious uveitis face lower recurrence rates when adalimumab is tapered slowly after remission. Medscape Medical News
JAK Inhibitors Offer Some Improvement for Pediatric Uveitis
Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred. Medscape Medical News
Probiotic Formula May Protect Infants With Milk Allergy
Children with cow’s milk protein allergy may have a lower incidence of allergic manifestations when their diet includes a probiotic-enhanced formula, new research shows. Medscape Medical News
Bruno Vision Care Receives FDA Approval for Deseyne® Contact Lens with FusionTechnology™
BOCA RATON, Fla.–(BUSINESS WIRE)–Bruno Vision Care LLC, a leader in eye care innovation, has received approval from the U.S. Food and Drug Administration (FDA) to sell its Deseyne® (vifilcon C) daily disposable contact lens with FusionTechnology™ in …
Social Media Aids Post-Op Care in Ectopia Lentis
Using a smartphone application for health education and reminders enhances parental understanding and boosts follow-up visits in children undergoing surgery for CEL. Medscape Medical News
OneLegacy Celebrates Donate Life Month Through Outreach and Awareness Activities Promoting the Power of Organ, Eye and Tissue Donation
LOS ANGELES–(BUSINESS WIRE)–OneLegacy, the local organ procurement organization that serves seven counties in Southern California, is joining thousands of organizations, hospitals, transplant centers, and cities across the country to celebrate Nation…
NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD
BUSAN, South Korea–(BUSINESS WIRE)– #BiopharmaceuticalCompany–NexThera completed the initial patient enrollment for its Phase 1/2a clinical trial of NT-101, a novel eye drop treatment for wet AMD.
Modest Effects of Valacyclovir in Herpes Zoster Eye Disease
Administration of low-dose valacyclovir over a year does not significantly reduce the occurrence of herpes zoster ophthalmicus but shows potential benefits over time. Medscape Medical News
7 Major Markets Stargardt Disease (STGD) Epidemiology Forecasts Report 2020-2024 & 2034: Focus on United States, EU4 (Germany, France, Italy, Spain), United Kingdom, and Japan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Stargardt Disease (STGD) – Epidemiology Forecast – 2034” report has been added to ResearchAndMarkets.com’s offering. The report delivers an in-depth understanding of STGD, historical and forecasted epidemiology in the Unit…
Updated Rosacea Treatment Algorithms Available
Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach wherein signs and symptoms guide diagnosis and treatment choices. Medscape Medical News
Viridian Therapeutics Appoints Jeff Ajer to its Board of Directors
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of Jeff Ajer…
FDA Approves First and Only Therapy for IgG4-RD
The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial. Medscape Medical News
Seven Years, a Hidden Metal Body, and Restored Eyesight
A metallic fragment, missed after a workplace injury, is removed 7 years later, fully restoring a 59-year-old man’s vision. Medscape UK
How Office Props Improve Patient Outcomes
Showing patients props and other visual aids improves recall of information, motivates patients, said doctors who have expanded their ‘black bags.’ Medscape Medical News
Early-Onset Atopic Dermatitis Raises Uveitis Risk in Kids
A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth. Medscape Medical News
US FDA Declines to Approve Aldeyra’s Eye Disease Drug
The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, the company said on Thursday, sending its shares… Reuters Health Information
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced receipt…
Sponsor Pulls Plug on Trials of Add-On AMD Treatment
An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 trials, so the sponsor halted both trials. Medscape Medical News
Gene Therapy: Medical Progress Has a Price, Says Ethicist
Ethicist Art Caplan discusses progress in gene therapy research and the need for medical professionals and regulators to tolerate appropriate risk. Medscape Business of Medicine